Philip S Low Selected Research

Fibrosis (Cirrhosis)

10/2020	Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models.
1/2020	Reprogramming of profibrotic macrophages for treatment of bleomycin-induced pulmonary fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip S Low Research Topics

Disease

131	Neoplasms (Cancer) 06/2024 - 05/2002
21	Inflammation (Inflammations) 10/2021 - 07/2002
19	Rheumatoid Arthritis 01/2022 - 04/2004
14	Arthritis (Polyarthritis) 01/2022 - 07/2002
11	Prostatic Neoplasms (Prostate Cancer) 06/2024 - 10/2008
10	Ovarian Neoplasms (Ovarian Cancer) 10/2022 - 09/2004
10	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2011
9	Lung Neoplasms (Lung Cancer) 04/2024 - 05/2002
9	Atherosclerosis 01/2018 - 05/2005
8	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 09/2007
7	Carcinoma (Carcinomatosis) 01/2023 - 09/2004
6	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022 - 06/2003
6	Malaria 10/2021 - 03/2004
6	Adenocarcinoma 01/2021 - 02/2013
5	Circulating Neoplastic Cells 04/2024 - 07/2007
5	Breast Neoplasms (Breast Cancer) 09/2023 - 09/2007
5	Bone Fractures (Bone Fracture) 10/2022 - 10/2015
5	Infections 01/2021 - 03/2004
5	Ovarian Epithelial Carcinoma 10/2019 - 03/2008
5	Adenocarcinoma of Lung 01/2017 - 01/2014
4	Parasitemia 10/2021 - 01/2016
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2020 - 10/2015
4	Ulcerative Colitis 01/2019 - 07/2012
4	Atherosclerotic Plaque (Atheroma) 01/2018 - 05/2005
4	Rupture 11/2016 - 11/2002
4	Experimental Arthritis 08/2016 - 01/2006
3	Glioma (Gliomas) 01/2023 - 01/2016
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 02/2013
3	Falciparum Malaria (Plasmodium falciparum Malaria) 10/2021 - 01/2016
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020 - 04/2015
3	Pituitary Neoplasms (Pituitary Adenoma) 12/2018 - 12/2013
3	Hypoxia (Hypoxemia) 10/2018 - 07/2016
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 05/2013
3	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 04/2008
2	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2016
2	Osteoarthritis 01/2022 - 01/2008
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2019
2	Cytokine Release Syndrome 10/2021 - 01/2019
2	Peritonitis 01/2021 - 01/2019
2	Fibrosis (Cirrhosis) 10/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

121	Folic Acid (Vitamin M)FDA LinkGeneric 04/2024 - 05/2002
38	LigandsIBA 06/2024 - 10/2003
20	PafolacianineIBA 04/2024 - 01/2016
18	Coloring Agents (Dyes)IBA 12/2023 - 04/2005
18	Folate Receptor 1IBA 09/2023 - 09/2006
18	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2002
16	Fluorescent Dyes (Fluorescent Probes)IBA 01/2022 - 10/2003
15	AntigensIBA 06/2024 - 04/2004
14	Fluorescein (Funduscein)FDA LinkGeneric 09/2023 - 05/2002
13	HaptensIBA 01/2017 - 05/2002
10	Contrast MediaIBA 04/2024 - 01/2008
10	AntibodiesIBA 01/2022 - 08/2003
9	Chimeric Antigen ReceptorsIBA 09/2023 - 05/2015
8	AcidsIBA 06/2024 - 05/2007
8	Folate Receptor 2IBA 01/2024 - 01/2015
8	Fluorescein-5-isothiocyanate (FITC)IBA 09/2023 - 01/2006
8	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 06/2011
7	Liposomes (Liposome)IBA 01/2018 - 09/2004
6	CytokinesIBA 01/2024 - 05/2002
6	Peptides (Polypeptides)IBA 10/2022 - 01/2015
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2006
6	VitaminsIBA 12/2008 - 05/2002
5	tubulysin BIBA 01/2020 - 07/2015
5	Monoclonal AntibodiesIBA 01/2019 - 07/2009
5	Carbonic Anhydrase IXIBA 10/2018 - 01/2016
5	EnzymesIBA 01/2018 - 09/2006
4	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 09/2005
4	poly(ethylene glycol)-folateIBA 01/2020 - 03/2013
4	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2020 - 01/2016
4	Cell Surface ReceptorsIBA 12/2019 - 05/2002
4	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 01/2006
4	Cholecystokinin B ReceptorIBA 03/2016 - 02/2014
3	MicroRNAs (MicroRNA)IBA 06/2024 - 08/2017
3	AluminumIBA 01/2023 - 01/2018
3	Imatinib Mesylate (Gleevec)FDA Link 10/2021 - 01/2016
3	Complement System Proteins (Complement)IBA 12/2019 - 09/2005
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2019 - 07/2015
3	isothiocyanic acidIBA 01/2019 - 06/2008
3	Protein Isoforms (Isoforms)IBA 01/2018 - 07/2012
3	SpectrinIBA 11/2016 - 08/2006
3	RadiopharmaceuticalsIBA 01/2016 - 07/2002
3	Indicators and Reagents (Reagents)IBA 06/2015 - 05/2009
3	Interleukin-2 (IL2)IBA 05/2014 - 05/2002
2	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2023
2	Toll-Like Receptor 7IBA 01/2024 - 01/2023
2	ParaffinIBA 01/2023 - 02/2013
2	BuffersIBA 01/2022 - 11/2005
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2016
2	Biotin (Vitamin H)FDA Link 01/2022 - 11/2016
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2021 - 01/2016
2	Phosphotransferases (Kinase)IBA 10/2021 - 11/2002
2	OligopeptidesIBA 10/2021 - 11/2018
2	AminopterinIBA 01/2021 - 04/2011

Therapy/Procedure

65	Therapeutics 01/2023 - 09/2002
18	Immunotherapy 11/2023 - 05/2002
8	Drug Therapy (Chemotherapy) 01/2019 - 08/2003
5	Cytoreduction Surgical Procedures 10/2019 - 09/2011
4	Intravenous Injections 01/2023 - 06/2013
3	Lasers (Laser) 10/2022 - 10/2003
2	Radiotherapy 01/2023 - 06/2008